Otelixizumab
Otelixizumab is a monoclonal antibody designed for the treatment of Type 1 diabetes. It is developed by GlaxoSmithKline and Tolerx, a biopharmaceutical company. Otelixizumab works by targeting the CD3 receptor, a protein on the surface of immune cells, to prevent the immune system's attack on beta cells in the pancreas.
Mechanism of Action
Otelixizumab is a monoclonal antibody that binds to the CD3 receptor on T cells. This binding action modulates the immune response, reducing the activity of the T cells that are responsible for the destruction of insulin-producing beta cells in the pancreas. This mechanism of action is intended to preserve the body's ability to produce insulin, thereby managing the symptoms of Type 1 diabetes.
Clinical Trials
Several clinical trials have been conducted to evaluate the safety and efficacy of Otelixizumab. The DEFEND-1 trial, a Phase III clinical trial, did not meet its primary endpoint of maintaining insulin production in patients with recent-onset Type 1 diabetes. However, some subgroups of patients did show a response to the treatment, indicating that further research may be needed to identify the patients most likely to benefit from Otelixizumab.
Potential Side Effects
As with all medications, Otelixizumab has the potential to cause side effects. The most common side effects observed in clinical trials include rash, nausea, fever, and headache. Serious side effects, including severe allergic reactions, have also been reported.
Future Research
Despite the setback in the DEFEND-1 trial, research into Otelixizumab continues. Future studies may focus on identifying the patient subgroups most likely to respond to the treatment, or on combining Otelixizumab with other therapies to enhance its efficacy.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD